Relationship of psychotropic medication use with physical function among postmenopausal women

Hind A. Beydoun,May A. Beydoun,Edward Kwon,Brook T. Alemu,Alan B. Zonderman,Robert Brunner
DOI: https://doi.org/10.1007/s11357-024-01141-z
2024-03-22
GeroScience
Abstract:Abstract To examine cross-sectional and longitudinal relationships of psychotropic medications with physical function after menopause. Analyses involved 4557 Women’s Health Initiative Long Life Study (WHI-LLS) participants (mean age at WHI enrollment (1993–1998): 62.8 years). Antidepressant, anxiolytic, and sedative/hypnotic medications were evaluated at WHI enrollment and 3-year follow-up visits. Performance-based physical function [Short Physical Performance Battery (SPPB)] was assessed at the 2012–2013 WHI-LLS visit. Self-reported physical function [RAND-36] was examined at WHI enrollment and the last available follow-up visit—an average of 22 [±2.8] (range: 12–27) years post-enrollment. Multivariable regression models controlled for socio-demographic, lifestyle, and health characteristics. Anxiolytics were not related to physical function. At WHI enrollment, antidepressant use was cross-sectionally related to worse self-reported physical function defined as a continuous ( β = −6.27, 95% confidence interval [CI]: −8.48, −4.07) or as a categorical (< 78 vs. ≥ 78) (odds ratio [OR] = 2.10, 95% CI: 1.48, 2.98) outcome. Antidepressant use at WHI enrollment was also associated with worse performance-based physical function (SPPB) [ 20 years of follow-up. Complex relationships found for hypnotic/sedatives were unexpected and necessitate further investigation.
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?